Abdominal discomfort in patients with rheumatoid arthritis is associated with physical and mental function, self-reported disease activity, and use of anti-inflammatory medication

Scandinavian Journal of Rheumatology

Volumn 42, Issue 4, 2013, Pages 333-335

  Austad, C ^a   Kvien, T K ^a   Uhlig, T ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL DISCOMFORT; ADULT; ARTHRALGIA; CHECKLIST; CLINICAL PRACTICE; COMORBIDITY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROPHYLAXIS; RATING SCALE; RHEUMATOID ARTHRITIS; RISK FACTOR; SELF EFFICACY SCALE FOR ILLNESS; SHORT FORM 36; VISUAL ANALOG SCALE;

ABDOMINAL PAIN; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; NORWAY; PAIN MEASUREMENT; QUESTIONNAIRES; REGISTRIES; RISK ASSESSMENT; SELF-ASSESSMENT; SICKNESS IMPACT PROFILE;

EID: 84880210234     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.773070     Document Type: Letter

References (11)

1. Rostom A, Muir K, Dubé C, Lanas A, Jolicoeur E, Tugwell P. Prevention of NSAID-related upper gastrointestinal toxicity: A meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009;1:47-71.
2. Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: A Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007;5:818-28.
3. Michaud K, Wolfe E. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885-906. (Pubitemid 47377810)
4. Myaseoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: Results from a population-based survey in Olmsted County, Minnesota. Gastroenterol Res Pract 2011;2011:745829.
5. Kvien TK, Glennas A, Knudsrød OG, Smedstad LM, Mowinckel P, Forre O. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 1997;26:412-18. (Pubitemid 28005043)
6. Kvien TK, Uhlig T. The Oslo experience with arthritis registries. Clin Exp Rhuematol 2003;31:315-24.
7. Pincus T, Summey JA, Soraci SA Jr, Walleston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53. (Pubitemid 14231480)
8. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
9. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989;32: 37-44. (Pubitemid 19034922)
10. Lanas A, Garcia-Tell G, Armada B, Oteo-Alvaro A. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med 2011; 9:38.
11. MacDonald TM, Morant SV, Goldstein JL, Burke TA, Pettitt D. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003;52: 1265-70. (Pubitemid 37026457)